These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 38102107)

  • 1. Identification of 5-HT
    Wallach J; Cao AB; Calkins MM; Heim AJ; Lanham JK; Bonniwell EM; Hennessey JJ; Bock HA; Anderson EI; Sherwood AM; Morris H; de Klein R; Klein AK; Cuccurazzu B; Gamrat J; Fannana T; Zauhar R; Halberstadt AL; McCorvy JD
    Nat Commun; 2023 Dec; 14(1):8221. PubMed ID: 38102107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of 5-HT
    Wallach J; Cao AB; Calkins MM; Heim AJ; Lanham JK; Bonniwell EM; Hennessey JJ; Bock HA; Anderson EI; Sherwood AM; Morris H; de Klein R; Klein AK; Cuccurazzu B; Gamrat J; Fannana T; Zauhar R; Halberstadt AL; McCorvy JD
    bioRxiv; 2023 Jul; ():. PubMed ID: 37577474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tolerance and Cross-Tolerance among Psychedelic and Nonpsychedelic 5-HT
    de la Fuente Revenga M; Jaster AM; McGinn J; Silva G; Saha S; González-Maeso J
    ACS Chem Neurosci; 2022 Aug; 13(16):2436-2448. PubMed ID: 35900876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of β-Arrestin-Biased 25CN-NBOH-Derived 5-HT
    Poulie CBM; Pottie E; Simon IA; Harpsøe K; D'Andrea L; Komarov IV; Gloriam DE; Jensen AA; Stove CP; Kristensen JL
    J Med Chem; 2022 Sep; 65(18):12031-12043. PubMed ID: 36099411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological Mechanism of the Non-hallucinogenic 5-HT
    Cunningham MJ; Bock HA; Serrano IC; Bechand B; Vidyadhara DJ; Bonniwell EM; Lankri D; Duggan P; Nazarova AL; Cao AB; Calkins MM; Khirsariya P; Hwu C; Katritch V; Chandra SS; McCorvy JD; Sames D
    ACS Chem Neurosci; 2023 Jan; 14(1):119-135. PubMed ID: 36521179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signaling snapshots of a serotonin receptor activated by the prototypical psychedelic LSD.
    Cao C; Barros-Álvarez X; Zhang S; Kim K; Dämgen MA; Panova O; Suomivuori CM; Fay JF; Zhong X; Krumm BE; Gumpper RH; Seven AB; Robertson MJ; Krogan NJ; Hüttenhain R; Nichols DE; Dror RO; Skiniotis G; Roth BL
    Neuron; 2022 Oct; 110(19):3154-3167.e7. PubMed ID: 36087581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of psychedelic new psychoactive substances (NPS) showing biased agonism at the 5-HT
    Pottie E; Dedecker P; Stove CP
    Biochem Pharmacol; 2020 Dec; 182():114251. PubMed ID: 32998000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-Activity Assessment and In-Depth Analysis of Biased Agonism in a Set of Phenylalkylamine 5-HT
    Pottie E; Poulie CBM; Simon IA; Harpsøe K; D'Andrea L; Komarov IV; Gloriam DE; Jensen AA; Kristensen JL; Stove CP
    ACS Chem Neurosci; 2023 Aug; 14(15):2727-2742. PubMed ID: 37474114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of the head-twitch response to investigate the structure-activity relationships of 4-thio-substituted 2,5-dimethoxyphenylalkylamines.
    Halberstadt AL; Luethi D; Hoener MC; Trachsel D; Brandt SD; Liechti ME
    Psychopharmacology (Berl); 2023 Jan; 240(1):115-126. PubMed ID: 36477925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Agonist-directed trafficking of signalling at serotonin 5-HT2A, 5-HT2B and 5-HT2C-VSV receptors mediated Gq/11 activation and calcium mobilisation in CHO cells.
    Cussac D; Boutet-Robinet E; Ailhaud MC; Newman-Tancredi A; Martel JC; Danty N; Rauly-Lestienne I
    Eur J Pharmacol; 2008 Oct; 594(1-3):32-8. PubMed ID: 18703043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure of a Hallucinogen-Activated Gq-Coupled 5-HT
    Kim K; Che T; Panova O; DiBerto JF; Lyu J; Krumm BE; Wacker D; Robertson MJ; Seven AB; Nichols DE; Shoichet BK; Skiniotis G; Roth BL
    Cell; 2020 Sep; 182(6):1574-1588.e19. PubMed ID: 32946782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-HT
    Schmitz GP; Jain MK; Slocum ST; Roth BL
    ACS Chem Neurosci; 2022 Aug; 13(16):2386-2398. PubMed ID: 35894503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential signaling signatures evoked by DOI versus lisuride stimulation of the 5-HT
    Banerjee AA; Vaidya VA
    Biochem Biophys Res Commun; 2020 Oct; 531(4):609-614. PubMed ID: 32814630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro structure-activity relationship determination of 30 psychedelic new psychoactive substances by means of β-arrestin 2 recruitment to the serotonin 2A receptor.
    Pottie E; Cannaert A; Stove CP
    Arch Toxicol; 2020 Oct; 94(10):3449-3460. PubMed ID: 32627074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychedelic-like Properties of Quipazine and Its Structural Analogues in Mice.
    de la Fuente Revenga M; Shah UH; Nassehi N; Jaster AM; Hemanth P; Sierra S; Dukat M; González-Maeso J
    ACS Chem Neurosci; 2021 Mar; 12(5):831-844. PubMed ID: 33400504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences across sexes on head-twitch behavior and 5-HT
    Jaster AM; Younkin J; Cuddy T; de la Fuente Revenga M; Poklis JL; Dozmorov MG; González-Maeso J
    Neurosci Lett; 2022 Sep; 788():136836. PubMed ID: 35963476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-based discovery of nonhallucinogenic psychedelic analogs.
    Cao D; Yu J; Wang H; Luo Z; Liu X; He L; Qi J; Fan L; Tang L; Chen Z; Li J; Cheng J; Wang S
    Science; 2022 Jan; 375(6579):403-411. PubMed ID: 35084960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychedelic-Induced Serotonin 2A Receptor Downregulation Does Not Predict Swim Stress Coping in Mice.
    Pędzich BD; Medrano M; Buckinx A; Smolders I; De Bundel D
    Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro assays for the functional characterization of (psychedelic) substances at the serotonin receptor 5-HT
    Pottie E; Stove CP
    J Neurochem; 2022 Jul; 162(1):39-59. PubMed ID: 34978711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic treatment with a metabotropic mGlu2/3 receptor agonist diminishes behavioral response to a phenethylamine hallucinogen.
    Halberstadt AL; van der Zee JVF; Chatha M; Geyer MA; Powell SB
    Psychopharmacology (Berl); 2019 Feb; 236(2):821-830. PubMed ID: 30448990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.